Six Pitfalls to Avoid in Supplier Management
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Managing suppliers is fraught with challenges. Rare is […]
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Managing suppliers is fraught with challenges. Rare is […]
For those attending BIO2008, I’ll be speaking on Friday morning: Title: Scientific Communications – Trends and Liabilities Track: Public Relations/Investor
For those attending BIO2008 in San Diego this year, I’ll be signing my books in the BIO bookstore on Wednesday
Guest content from Sandy Graham, managing partner at Sequoyah Associates: Can you “see the field” of opportunity? Have your clearly
Did you know that BiotechBlog posts are syndicated to outlets such as Reuters, Biospace, San Francisco Gate, Chicago Sun-Times, and
The Journal of Commercial Biotechnology is looking for papers on investing strategies in the biotechnology space. The scope can include
For those attending BIO2008 in San Diego this year, I’ll be doing a signing of my books on Wednesday June
I’ve nearly completed revisions for the third edition of Building Biotechnology, the leading textbook on the business of biotechnology. This
Seeking reviewers and contributors for next edition of Building Biotechnology Read Post »
The science of biotechnology is tough. R&D can be unpredictable, and most products need regulatory approval before they can be
Dyadic founder fights to regain control of company Read Post »
Apologies for light posting as of late. I’ve been buried deep in revisions to Building Biotechnology and prepping for an
Get new actionable insights and updates from BiotechBlog